324 related articles for article (PubMed ID: 35397018)
1. Reference materials for MS-based untargeted metabolomics and lipidomics: a review by the metabolomics quality assurance and quality control consortium (mQACC).
Lippa KA; Aristizabal-Henao JJ; Beger RD; Bowden JA; Broeckling C; Beecher C; Clay Davis W; Dunn WB; Flores R; Goodacre R; Gouveia GJ; Harms AC; Hartung T; Jones CM; Lewis MR; Ntai I; Percy AJ; Raftery D; Schock TB; Sun J; Theodoridis G; Tayyari F; Torta F; Ulmer CZ; Wilson I; Ubhi BK
Metabolomics; 2022 Apr; 18(4):24. PubMed ID: 35397018
[TBL] [Abstract][Full Text] [Related]
2. Dissemination and analysis of the quality assurance (QA) and quality control (QC) practices of LC-MS based untargeted metabolomics practitioners.
Evans AM; O'Donovan C; Playdon M; Beecher C; Beger RD; Bowden JA; Broadhurst D; Clish CB; Dasari S; Dunn WB; Griffin JL; Hartung T; Hsu PC; Huan T; Jans J; Jones CM; Kachman M; Kleensang A; Lewis MR; Monge ME; Mosley JD; Taylor E; Tayyari F; Theodoridis G; Torta F; Ubhi BK; Vuckovic D;
Metabolomics; 2020 Oct; 16(10):113. PubMed ID: 33044703
[TBL] [Abstract][Full Text] [Related]
3. Establishing a framework for best practices for quality assurance and quality control in untargeted metabolomics.
Mosley JD; Schock TB; Beecher CW; Dunn WB; Kuligowski J; Lewis MR; Theodoridis G; Ulmer Holland CZ; Vuckovic D; Wilson ID; Zanetti KA
Metabolomics; 2024 Feb; 20(2):20. PubMed ID: 38345679
[TBL] [Abstract][Full Text] [Related]
4. Metabolomics 2022 workshop report: state of QA/QC best practices in LC-MS-based untargeted metabolomics, informed through mQACC community engagement initiatives.
Dunn WB; Kuligowski J; Lewis M; Mosley JD; Schock T; Ulmer Holland C; Zanetti KA; Vuckovic D;
Metabolomics; 2023 Nov; 19(11):93. PubMed ID: 37940740
[TBL] [Abstract][Full Text] [Related]
5. Towards quality assurance and quality control in untargeted metabolomics studies.
Beger RD; Dunn WB; Bandukwala A; Bethan B; Broadhurst D; Clish CB; Dasari S; Derr L; Evans A; Fischer S; Flynn T; Hartung T; Herrington D; Higashi R; Hsu PC; Jones C; Kachman M; Karuso H; Kruppa G; Lippa K; Maruvada P; Mosley J; Ntai I; O'Donovan C; Playdon M; Raftery D; Shaughnessy D; Souza A; Spaeder T; Spalholz B; Tayyari F; Ubhi B; Verma M; Walk T; Wilson I; Witkin K; Bearden DW; Zanetti KA
Metabolomics; 2019 Jan; 15(1):4. PubMed ID: 30830465
[TBL] [Abstract][Full Text] [Related]
6. Quality assurance and quality control reporting in untargeted metabolic phenotyping: mQACC recommendations for analytical quality management.
Kirwan JA; Gika H; Beger RD; Bearden D; Dunn WB; Goodacre R; Theodoridis G; Witting M; Yu LR; Wilson ID;
Metabolomics; 2022 Aug; 18(9):70. PubMed ID: 36029375
[TBL] [Abstract][Full Text] [Related]
7. Mass Spectrometry-Based Untargeted Metabolomics and Lipidomics Platforms to Analyze Cell Culture Extracts.
Iturrospe E; da Silva KM; van de Lavoir M; Robeyns R; Cuykx M; Vanhaecke T; van Nuijs ALN; Covaci A
Methods Mol Biol; 2023; 2571():189-206. PubMed ID: 36152163
[TBL] [Abstract][Full Text] [Related]
8. NIST lipidomics workflow questionnaire: an assessment of community-wide methodologies and perspectives.
Bowden JA; Ulmer CZ; Jones CM; Koelmel JP; Yost RA
Metabolomics; 2018 Mar; 14(5):53. PubMed ID: 30830346
[TBL] [Abstract][Full Text] [Related]
9. Ensuring the reliability of stable isotope ratio data--beyond the principle of identical treatment.
Carter JF; Fry B
Anal Bioanal Chem; 2013 Mar; 405(9):2799-814. PubMed ID: 23274555
[TBL] [Abstract][Full Text] [Related]
10. Quality assurance procedures for mass spectrometry untargeted metabolomics. a review.
Dudzik D; Barbas-Bernardos C; García A; Barbas C
J Pharm Biomed Anal; 2018 Jan; 147():149-173. PubMed ID: 28823764
[TBL] [Abstract][Full Text] [Related]
11. The importance of experimental design and QC samples in large-scale and MS-driven untargeted metabolomic studies of humans.
Dunn WB; Wilson ID; Nicholls AW; Broadhurst D
Bioanalysis; 2012 Sep; 4(18):2249-64. PubMed ID: 23046267
[TBL] [Abstract][Full Text] [Related]
12. Long-Term Metabolomics Reference Material.
Gouveia GJ; Shaver AO; Garcia BM; Morse AM; Andersen EC; Edison AS; McIntyre LM
Anal Chem; 2021 Jul; 93(26):9193-9199. PubMed ID: 34156835
[TBL] [Abstract][Full Text] [Related]
13. Current Practices in LC-MS Untargeted Metabolomics: A Scoping Review on the Use of Pooled Quality Control Samples.
Broeckling CD; Beger RD; Cheng LL; Cumeras R; Cuthbertson DJ; Dasari S; Davis WC; Dunn WB; Evans AM; Fernández-Ochoa A; Gika H; Goodacre R; Goodman KD; Gouveia GJ; Hsu PC; Kirwan JA; Kodra D; Kuligowski J; Lan RS; Monge ME; Moussa LW; Nair SG; Reisdorph N; Sherrod SD; Ulmer Holland C; Vuckovic D; Yu LR; Zhang B; Theodoridis G; Mosley JD
Anal Chem; 2023 Dec; 95(51):18645-18654. PubMed ID: 38055671
[TBL] [Abstract][Full Text] [Related]
14. Replication of LC-MS untargeted lipidomics results in patients with calcific coronary disease: An interlaboratory reproducibility study.
Djekic D; Pinto R; Vorkas PA; Henein MY
Int J Cardiol; 2016 Nov; 222():1042-1048. PubMed ID: 27543723
[TBL] [Abstract][Full Text] [Related]
15. Advanced tandem mass spectrometry in metabolomics and lipidomics-methods and applications.
Heiles S
Anal Bioanal Chem; 2021 Oct; 413(24):5927-5948. PubMed ID: 34142202
[TBL] [Abstract][Full Text] [Related]
16. A perspective on the standards describing mass spectrometry-based metabolic phenotyping (metabolomics/metabonomics) studies in publications.
Wilson ID; Theodoridis G; Virgiliou C
J Chromatogr B Analyt Technol Biomed Life Sci; 2021 Feb; 1164():122515. PubMed ID: 33460910
[TBL] [Abstract][Full Text] [Related]
17. Trapped ion mobility spectrometry-mass spectrometry improves the coverage and accuracy of four-dimensional untargeted lipidomics.
Chen X; Yin Y; Luo M; Zhou Z; Cai Y; Zhu ZJ
Anal Chim Acta; 2022 Jun; 1210():339886. PubMed ID: 35595363
[TBL] [Abstract][Full Text] [Related]
18. Model-driven data curation pipeline for LC-MS-based untargeted metabolomics.
Riquelme G; Bortolotto EE; Dombald M; Monge ME
Metabolomics; 2023 Mar; 19(3):15. PubMed ID: 36856823
[TBL] [Abstract][Full Text] [Related]
19. Guidelines and considerations for the use of system suitability and quality control samples in mass spectrometry assays applied in untargeted clinical metabolomic studies.
Broadhurst D; Goodacre R; Reinke SN; Kuligowski J; Wilson ID; Lewis MR; Dunn WB
Metabolomics; 2018; 14(6):72. PubMed ID: 29805336
[TBL] [Abstract][Full Text] [Related]
20. Metabolomics and lipidomics using traveling-wave ion mobility mass spectrometry.
Paglia G; Astarita G
Nat Protoc; 2017 Apr; 12(4):797-813. PubMed ID: 28301461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
